Rare COVID Vaccine Clotting Linked to Adenoviral Protein  - Top-Institutions - MDSpire

Rare COVID Vaccine Clotting Linked to Adenoviral Protein 

Antibody proteomics and immunogenetics identify adenoviral protein VII as the trigger of PF4-targeting antibodies 

  • April 21, 2026

  • 2 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Hematology
    • Infectious Diseases
    • Vaccine Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Immunology
    • Clinical Research

  • #3

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Immunology
    • Vaccine Development
    • Hematology

  • #4

    Massachusetts General Hospital (MGH) - Center for Immunology and Inflammatory Diseases
    Massachusetts General Hospital (MGH) - Center for Immunology and Inflammatory Diseases

    Boston, MA

    Key Differentiators

    • Immunology
    • Hematology
    • Translational Medicine

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Hematology
    • Immunology
    • Infectious Diseases

Original Source(s)

Rare COVID Vaccine Clotting Linked to Adenoviral Protein 

  • April 21, 2026

Related Content

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave

Human Papillomavirus Vaccine Discourse and Sentiment on Reddit Before and After COVID-19: Mixed Methods Retrospective Cross-Sectional Study

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis